This week on "The Readout LOUD" podcast: an AI experiment at the FDA and how Novo Nordisk is trailing in the obesity drug ...

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

A large government study published Thursday shows more definitively than ever before that Americans’ self-reported race is a ...

The NIH archives of the Human Genome Project could fall victim to Trump administration cuts, writes a former archivist.

With millions of people at risk of losing health insurance under Trump’s tax bill, lawmakers have begun lobbying the ...

The rewriting of government recommendations will make the effort to get vaccine doses into arms exponentially more difficult, ...

The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...

A study shows levels of the amino acid taurine rise rather than fall over time, confounding the goal of dietary supplements ...

Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...

And it’s never a bad time to re-read some of the team’s excellent, award-winning coverage on the company: Last week, key ...

Exclusive: OpenEvidence aims to be ‘Disney+’ with new JAMA deal. OpenEvidence this morning announced it has a new multi-year ...

U.S. research on HIV, tuberculosis, Covid-19, mpox, and other fast-moving epidemics is under threat by a hastily announced ...